No consensus on the optimal palliative radiotherapy regimen for people with inoperable non-small-cell lung cancer
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 29 (5) , 445-447
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancerAnnals of Oncology, 2001
- Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of LifeJournal of Clinical Oncology, 1999
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1999
- Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995